{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:19:57Z","timestamp":1778642397674,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013799","name":"Jilin Engineering Normal University","doi-asserted-by":"publisher","award":["BSKJ202002"],"award-info":[{"award-number":["BSKJ202002"]}],"id":[{"id":"10.13039\/501100013799","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.intimp.2020.106702","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T12:10:45Z","timestamp":1592482245000},"page":"106702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Network pharmacology strategy for predicting the correlation of Systemic Scleroderma with Vitamin D deficiency"],"prefix":"10.1016","volume":"86","author":[{"given":"Shizhe","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoqun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.intimp.2020.106702_b0005","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.autrev.2015.07.012","article-title":"Quality of life in systemic sclerosis","volume":"14","author":"Almeida","year":"2015","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.intimp.2020.106702_b0010","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.autrev.2016.01.007","article-title":"Systemic sclerosis: an update in 2016","volume":"15","author":"Desbois","year":"2016","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2020.106702_b0015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.semarthrit.2018.12.007","article-title":"Ocular involvement in systemic sclerosis: a systematic literature review, it's not all scleroderma that meets the eye","volume":"49","author":"Kreps","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.intimp.2020.106702_b0020","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4103\/idoj.IDOJ_328_17","article-title":"Evaluation of serum vitamin D levels in patients with systemic sclerosis and healthy controls: results of a pilot study","volume":"9","author":"Gupta","year":"2018","journal-title":"Indian Dermatol. Online J."},{"issue":"3","key":"10.1016\/j.intimp.2020.106702_b0025","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0190-9622(88)70070-5","article-title":"Systemic scleroderma: clinical and pathophysiologic aspects","volume":"18","author":"Thomas Krieg","year":"1988","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106702_b0030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/rheumatology\/keq176","article-title":"Early systemic sclerosis: assessment of clinical and pre-clinical organ involvement in patients with different disease features","volume":"50","author":"Valentini","year":"2011","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.intimp.2020.106702_b0035","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.autrev.2009.02.018","article-title":"Anti-topoisomerase I autoantibodies in systemic sclerosis","volume":"8","author":"Czompoly","year":"2009","journal-title":"Autoimmun. Rev."},{"issue":"3","key":"10.1016\/j.intimp.2020.106702_b0040","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.maturitas.2014.12.018","article-title":"The role of vitamin D in osteoporosis","volume":"80","author":"Brincat","year":"2015","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.intimp.2020.106702_b0045","doi-asserted-by":"crossref","first-page":"331","DOI":"10.5114\/ceji.2018.80053","article-title":"The immunological implication of the new vitamin D metabolism","volume":"43","author":"Bivona","year":"2018","journal-title":"Central-Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106702_b0050","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1177\/0976001620060205","article-title":"Vitamin D deficiency","volume":"3","author":"Virmani","year":"2006","journal-title":"Apollo Med."},{"issue":"2","key":"10.1016\/j.intimp.2020.106702_b0055","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/rheumatology\/kew212","article-title":"Vitamin D treatment for connective tissue diseases: hope beyond the hype","volume":"56","author":"Reynolds","year":"2017","journal-title":"Rheumatology"},{"issue":"357","key":"10.1016\/j.intimp.2020.106702_b0060","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","author":"Holick","year":"2007","journal-title":"The New England J. Med."},{"issue":"7","key":"10.1016\/j.intimp.2020.106702_b0065","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3390\/medicina55070341","article-title":"Non-skeletal activities of vitamin D: from physiology to brain pathology","volume":"55","author":"Bivona","year":"2019","journal-title":"Medicina"},{"issue":"12","key":"10.1016\/j.intimp.2020.106702_b0070","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s10067-010-1478-3","article-title":"Very low levels of vitamin D in systemic sclerosis patients","volume":"29","author":"Caramaschi","year":"2010","journal-title":"Clin. Rheumatol."},{"issue":"11","key":"10.1016\/j.intimp.2020.106702_b0075","first-page":"2492","article-title":"Significantly decreased serum 25-hydroxyvitamin D levels in a Larget German systemic sclerosis cohort","volume":"38","author":"Thilo Gambichler","year":"2011","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.intimp.2020.106702_b0080","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.2147\/DDDT.S144860","article-title":"Vitamin D levels in systemic sclerosis patients: a meta-analysis","volume":"11","author":"An","year":"2017","journal-title":"Drug Des. Develop. Therapy"},{"key":"10.1016\/j.intimp.2020.106702_b0085","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cca.2016.04.026","article-title":"Association between hypovitaminosis D and systemic sclerosis: true or fake?","volume":"458","author":"Bivona","year":"2016","journal-title":"Clin. Chim. Acta"},{"issue":"8","key":"10.1016\/j.intimp.2020.106702_b0090","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.autrev.2011.02.002","article-title":"Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature","volume":"10","author":"Arnson","year":"2011","journal-title":"Autoimmun. Rev."},{"issue":"6","key":"10.1016\/j.intimp.2020.106702_b0095","doi-asserted-by":"crossref","first-page":"e0179062","DOI":"10.1371\/journal.pone.0179062","article-title":"Vitamin D deficiency and clinical correlations in systemic sclerosis patients: a retrospective analysis for possible future developments","volume":"12","author":"Trombetta","year":"2017","journal-title":"PLoS ONE"},{"issue":"37","key":"10.1016\/j.intimp.2020.106702_b0100","first-page":"S76","article-title":"Vitamin D increases the production of IL-10 by regulatory T cells in patients with systemic sclerosis","author":"Di Liberto","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"issue":"6","key":"10.1016\/j.intimp.2020.106702_b0105","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3899\/jrheum.091143","article-title":"Vitamin D deficiency in a cohort of patients with systemic scleroderma from the south of Spain","volume":"37","author":"Rios Fernandez","year":"2010","journal-title":"J. Rheumatol."},{"issue":"9","key":"10.1016\/j.intimp.2020.106702_b0110","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.3899\/jrheum.081287","article-title":"Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with systemic sclerosis","volume":"36","author":"Vacca","year":"2009","journal-title":"J. Rheumatol."},{"issue":"3","key":"10.1016\/j.intimp.2020.106702_b0115","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-3083.2008.02127.x","article-title":"The complex role of vitamin D in autoimmune diseases","volume":"68","author":"Szodoray","year":"2008","journal-title":"Scand. J. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2020.106702_b0120","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1002\/art.24801","article-title":"Loss of beta1 integrin in mouse fibroblasts results in resistance to skin scleroderma in a mouse model","volume":"60","author":"Liu","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.intimp.2020.106702_b0125","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1038\/s41598-019-41153-w","article-title":"Identification of regulators of the myofibroblast phenotype of primary dermal fibroblasts from early diffuse systemic sclerosis patients","volume":"9","author":"Chadli","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2020.106702_b0130","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bcp.2018.07.047","article-title":"EHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates bleomycin-induced skin and lung fibrosis","volume":"157","author":"Garcia-Martin","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2020.106702_b0135","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.jaci.2007.12.1159","article-title":"Transforming growth factor beta 1 increases fibronectin deposition through integrin receptor alpha 5 beta 1 on human airway smooth muscle","volume":"121","author":"Moir","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2020.106702_b0140","doi-asserted-by":"crossref","first-page":"7708","DOI":"10.4049\/jimmunol.175.11.7708","article-title":"Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts","volume":"175","author":"Asano","year":"2005","journal-title":"J. Immunol."},{"issue":"19","key":"10.1016\/j.intimp.2020.106702_b0145","first-page":"568","article-title":"Molecular pathways as novel therapeutic targets in systemic sclerosis","author":"Varga","year":"2007","journal-title":"Curr. Opin. Rheumatol."},{"issue":"3","key":"10.1016\/j.intimp.2020.106702_b0150","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.thromres.2005.03.003","article-title":"Increase in platelet non-integrin type I collagen receptor in patients with systemic sclerosis","volume":"117","author":"Chiang","year":"2006","journal-title":"Thromb. Res."},{"issue":"11","key":"10.1016\/j.intimp.2020.106702_b0155","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/apt.14631","article-title":"Review article: nonclinical and clinical pharmacology, pharmacokinetics and pharmacodynamics of etrolizumab, an anti-beta7 integrin therapy for inflammatory bowel disease","volume":"47","author":"Tang","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2020.106702_b0160","doi-asserted-by":"crossref","first-page":"12994","DOI":"10.1038\/s41598-019-49385-6","article-title":"Reduction of integrin alpha 4 activity through splice modulating antisense oligonucleotides","volume":"9","author":"Aung-Htut","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2020.106702_b0165","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/intimm\/dxu096","article-title":"Therapeutic uses of anti-alpha4-integrin (anti-VLA-4) antibodies in multiple sclerosis","volume":"27","author":"Schwab","year":"2015","journal-title":"Int. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2020.106702_b0170","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0002-9343(69)90044-8","article-title":"Pathologic obesrvations in systemic sclerosis (scleroderma)","volume":"46","author":"Angelo","year":"1969","journal-title":"Am. J. Med."},{"issue":"8","key":"10.1016\/j.intimp.2020.106702_b0175","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1002\/art.23677","article-title":"Rho-associated kinases are crucial for myofibroblast differentiation and production of extracellular matrix in scleroderma fibroblasts","volume":"58","author":"Akhmetshina","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.intimp.2020.106702_b0180","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4196\/kjpp.2019.23.2.141","article-title":"Far-infrared radiation stimulates platelet-derived growth factor mediated skeletal muscle cell migration through extracellular matrix-integrin signaling","volume":"23","author":"Lee","year":"2019","journal-title":"Korean J. Physiol. Pharmacol.: Offic. J. Korean Physiol. Soc. Korean Soc. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106702_b0185","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0962-8924(98)80005-6","article-title":"Cell migration: regulation of force on extracellular-matrix-integrin complexes","volume":"8","author":"Sheetz","year":"1998","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.intimp.2020.106702_b0190","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.2147\/IJN.S80502","article-title":"Functionalized self-assembling peptide improves INS-1 beta-cell function and proliferation via the integrin\/FAK\/ERK\/cyclin pathway","volume":"10","author":"Liu","year":"2015","journal-title":"Int. J. Nanomed."},{"issue":"5651","key":"10.1016\/j.intimp.2020.106702_b0195","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1126\/science.1092053","article-title":"Cell migration: integrating signals from front to back","volume":"302","author":"Ridley","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.intimp.2020.106702_b0200","doi-asserted-by":"crossref","first-page":"1790808","DOI":"10.1155\/2017\/1790808","article-title":"Fibrillar type I collagen enhances the differentiation and proliferation of myofibroblasts by lowering alpha2beta1 integrin expression in cardiac fibrosis","volume":"2017","author":"Hong","year":"2017","journal-title":"Biomed. Res. Int."},{"issue":"4","key":"10.1016\/j.intimp.2020.106702_b0205","doi-asserted-by":"crossref","first-page":"e94496","DOI":"10.1371\/journal.pone.0094496","article-title":"Identification of a role for the PI3K\/AKT\/mTOR signaling pathway in innate immune cells","volume":"9","author":"Xie","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2020.106702_b0210","first-page":"1","article-title":"Dahuang Zhechong pill attenuates CCl4-induced rat liver fibrosis via the PI3K-Akt signaling pathway","author":"Gong","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.intimp.2020.106702_b0215","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.molimm.2019.03.015","article-title":"PI3K activity in dendritic cells exerts paradoxical effects during autoimmune inflammation","volume":"111","author":"Datler","year":"2019","journal-title":"Mol. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2020.106702_b0220","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.jaci.2019.03.017","article-title":"PI3K pathway defects leading to immunodeficiency and immune dysregulation","volume":"143","author":"Nunes-Santos","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2020.106702_b0225","doi-asserted-by":"crossref","first-page":"e41994","DOI":"10.1371\/journal.pone.0041994","article-title":"Periostin facilitates skin sclerosis via PI3K\/Akt dependent mechanism in a mouse model of scleroderma","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.intimp.2020.106702_b0230","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/ard.2006.056424","article-title":"Risk factors for lung cancer in patients with scleroderma: a nested case-control study","volume":"66","author":"Pontifex","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.intimp.2020.106702_b0235","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.autrev.2012.06.003","article-title":"Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature","volume":"12","author":"Colaci","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2020.106702_b0240","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.gene.2019.02.076","article-title":"The relation between PI3K\/AKT signalling pathway and cancer","volume":"698","author":"Noorolyai","year":"2019","journal-title":"Gene"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920312145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920312145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:51:54Z","timestamp":1769028714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920312145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":48,"alternative-id":["S1567576920312145"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106702","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Network pharmacology strategy for predicting the correlation of Systemic Scleroderma with Vitamin D deficiency","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106702","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106702"}}